Home » Topics » Conferences

Conferences
RSS

LTA4 hydrolase inhibitor effective in ulcerative colitis

Oct. 18, 1996

Servier selects TxA2 antagonist for further study

Oct. 18, 1996

Antithrombotic prostaglandin analogue revealed by Asahi Glass

Oct. 18, 1996

New FLAP inhibitor presented by Abbott

Oct. 18, 1996

CGP-57698: Follow-up compound to iralukast reported by Ciba-Geigy

Oct. 18, 1996

Menarini studies LTD4 antagonists for asthma Rx

Oct. 18, 1996

PDR Meeting

Oct. 18, 1996

New cPLA2 inhibitor from Merckle

Oct. 18, 1996

New antioxidant for atherosclerosis

Oct. 11, 1996

New use for Uriach's rupatadine

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...